Arcutis Biotherapeutics, Inc. (ARQT) Soars to 52-Week High, Time to Cash Out?
A strong stock as of late has been Arcutis Biotherapeutics, Inc. (ARQT) . Shares have been marching higher, with the stock up 40.8% over the past month. The stock hit a new 52-week high of $28.96 in the previous session. Arcutis Biotherapeutics has gained 100.2% since the start of the year compared to the 4.8% move for the Zacks Medical sector and the 15.8% return for the Zacks Medical - Biomedical and Genetics industry.What's Driving the Outperformance?The stock has a great record of positive earnings surp ...